Trademark: 85082509
Word
IMMIPRINT
Status
Dead
Status Code
605
Status Date
Thursday, November 14, 2013
Serial Number
85082509
Mark Type
4000
Filing Date
Monday, July 12, 2010
Published for Opposition
Tuesday, September 20, 2011
Abandoned Date
Wednesday, November 13, 2013

Trademark Owner History
ProteinLogic Limited - Owner At Publication

Classifications
1 Chemical and biochemical assays and reagents for use in science, industrial research and medical research
5 Medical and veterinary diagnostic test set-ups composed primarily of chemical and/or biochemical reagents used in diagnosing human and animal diseases; diagnostic preparations for medical and veterinary purposes; chemical reagents for medical or veterinary purposes; reagents for medical or veterinary diagnostic purposes
10 Apparatus for clinical, medical and veterinary diagnosis, namely, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic biochips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing: medical and veterinary testing apparatus for diagnosing human and animal diseases, in particular ones containing chemical and/or biochemical reagents, namely, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic bio-chips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; laboratory apparatus and equipment for use in the detection of soluble CD antigens, soluble immune system proteins and other soluble proteins in bodily fluids all for diagnosis and monitoring of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases, namely, microplate readers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, antibody biochips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, flow cytometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, immuno detectors for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, microfluidic bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, photometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, piezo electrical transducers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification; scientific apparatus and equipment for use in the detection of soluble CD antigens, soluble immune system proteins and other soluble proteins in bodily fluids all for use in the diagnosis and monitoring of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases, namely, microplate readers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, antibody bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, flow cytometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, immuno detectors for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, microfluidic bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, photometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, piezo electrical transducers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification
44 Medical analyses, namely, RNA or DNA analyses for diagnosing human and animal diseases and forecasting the expected progress of human and animal diseases, all provided during the course of medical treatment or diagnosis and not for medical research purposes
Color is not claimed as a feature of the mark.

Trademark Events
Nov 14, 2013
Abandonment Notice Mailed - After Publication
Nov 14, 2013
Abandonment - After Publication
Nov 13, 2013
Teas Express Abandonment Received
May 16, 2013
Notice Of Approval Of Extension Request E-Mailed
May 15, 2013
Extension 3 Granted
May 10, 2013
Extension 3 Filed
May 10, 2013
Teas Extension Received
Nov 14, 2012
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2012
Extension 2 Granted
Nov 9, 2012
Extension 2 Filed
Nov 9, 2012
Teas Extension Received
May 22, 2012
Notice Of Approval Of Extension Request E-Mailed
May 18, 2012
Extension 1 Granted
Apr 26, 2012
Extension 1 Filed
May 18, 2012
Case Assigned To Intent To Use Paralegal
Apr 26, 2012
Teas Extension Received
Nov 15, 2011
Noa E-Mailed - Sou Required From Applicant
Sep 20, 2011
Official Gazette Publication Confirmation E-Mailed
Sep 20, 2011
Published For Opposition
Aug 17, 2011
Law Office Publication Review Completed
Aug 8, 2011
Assigned To Lie
Jul 26, 2011
Approved For Pub - Principal Register
Jul 26, 2011
Examiner's Amendment Entered
Jul 26, 2011
Notification Of Examiners Amendment E-Mailed
Jul 26, 2011
Examiners Amendment E-Mailed
Jul 26, 2011
Examiners Amendment -Written
Feb 7, 2011
Notification Of Final Refusal Emailed
Feb 7, 2011
Final Refusal E-Mailed
Feb 7, 2011
Final Refusal Written
Jan 18, 2011
Teas/Email Correspondence Entered
Jan 17, 2011
Correspondence Received In Law Office
Jan 17, 2011
Teas Response To Office Action Received
Oct 25, 2010
Notification Of Non-Final Action E-Mailed
Oct 25, 2010
Non-Final Action E-Mailed
Oct 25, 2010
Non-Final Action Written
Oct 25, 2010
Assigned To Examiner
Jul 15, 2010
New Application Office Supplied Data Entered In Tram
Jul 15, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24